[4-[6-methoxy-5-[(1-methyl-2-oxo-3-pyridinyl)carbamoyl]indazol-2-yl]cyclohexyl]methyl N-methylcarbamate
C24H29N5O5 — CID 169132492
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[6-methoxy-5-[(1-methyl-2-oxo-3-pyridinyl)carbamoyl]indazol-2-yl]cyclohexyl]methyl N-methylcarbamate
[4-[6-methoxy-5-[(1-methyl-2-oxo-3-pyridinyl)carbamoyl]indazol-2-yl]cyclohexyl]methyl N-methylcarbamate (PubChem CID 169132492) has the molecular formula C24H29N5O5 and a molecular weight of 467.53 g/mol. Its IUPAC name is [4-[6-methoxy-5-[(1-methyl-2-oxo-3-pyridinyl)carbamoyl]indazol-2-yl]cyclohexyl]methyl N-methylcarbamate.
Molecular Properties
| Compound Name | [4-[6-methoxy-5-[(1-methyl-2-oxo-3-pyridinyl)carbamoyl]indazol-2-yl]cyclohexyl]methyl N-methylcarbamate |
|---|---|
| PubChem CID | 169132492 |
| Molecular Formula | C24H29N5O5 |
| Molecular Weight | 467.53 g/mol |
| Exact Mass | 467.22 |
| IUPAC Name | [4-[6-methoxy-5-[(1-methyl-2-oxo-3-pyridinyl)carbamoyl]indazol-2-yl]cyclohexyl]methyl N-methylcarbamate |
| SMILES | CNC(=O)OCC1CCC(n2cc3cc(C(=O)Nc4cccn(C)c4=O)c(OC)cc3n2)CC1 |
| InChI | InChI=1S/C24H29N5O5/c1-25-24(32)34-14-15-6-8-17(9-7-15)29-13-16-11-18(21(33-3)12-20(16)27-29)22(30)26-19-5-4-10-28(2)23(19)31/h4-5,10-13,15,17H,6-9,14H2,1-3H3,(H,25,32)(H,26,30) |
| InChIKey | VXTARPIHSUNTDM-UHFFFAOYSA-N |
| XLogP | 3.08 |
| TPSA | 116.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 467.53 |
| LogP ≤ 5 | 3.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169132492 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.